Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Spero Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Spero Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Spero Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Spero Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Spero Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Spero Therapeutics Inc, Pharmaceuticals & Healthcare, Deal Details 12
Asset Purchase 12
Spero Therapeutics Acquires Next Generation Antibacterial Candidates from Pro Bono Bio 12
Spero Therapeutics Acquires Rights to Novel Gyrase Inhibitors from Vertex Pharma 13
Spero Therapeutics Acquires Antibiotic Assets from Biota Pharma (Aviragen Therapeutics) 14
Venture Financing 15
Spero Therapeutics Raises USD51.7 Million in Series C Financing 15
Spero Therapeutics Raises USD30 Million in Series B Funding 17
Spero Therapeutics Raises USD30 Million in Extended Series A Financing 19
Spero Therapeutics Secures Venture Funding 21
Spero Therapeutics Raises USD3 Million in Series A Venture Financing 22
Partnerships 23
Spero Therapeutics Enters into Agreement with US Department of Defense 23
Evotec Extends its Agreement with Spero Therapeutics 24
Licensing Agreements 25
Spero Therapeutics Enters into Licensing Agreement with Meiji Seika Pharma 25
Spero Therapeutics Enters into Licensing Agreement with Promiliad Biopharma 26
Spero Therapeutics Amends Licensing Agreement with Northern Antibiotics 27
Equity Offering 28
Spero Therapeutics Raises USD75 Million in Public Offering of Shares 28
Spero Therapeutics Raises USD77 Million in IPO 30
Spero Therapeutics Inc – Key Competitors 32
Spero Therapeutics Inc – Key Employees 33
Spero Therapeutics Inc – Locations And Subsidiaries 34
Head Office 34
Other Locations & Subsidiaries 34
Recent Developments 35
Financial Announcements 35
Aug 09, 2018: Spero Therapeutics announces second quarter 2018 financial results and pipeline overview 35
May 10, 2018: Spero Therapeutics Announces First Quarter 2018 Financial Results and Pipeline Update 37
Apr 02, 2018: Spero Therapeutics Announces Fourth Quarter and Full Year 2017 Operating Results and Provides Pipeline Update 39
Dec 14, 2017: Spero Therapeutics Announces 3Q17 Operating Results and Pipeline Update 41
Corporate Communications 43
Aug 14, 2018: Spero announces appointment of John C. Pottage, Jr., MD to its board of directors 43
Feb 01, 2018: Spero Announces Appointment of David P. Southwell to its Board of Directors 44
Jan 04, 2018: Spero Therapeutics Appoints David Melnick, M.D., as Chief Medical Officer 45
Sep 06, 2017: Spero Announces Appointment of Frank Thomas to its Board of Directors and Promotions within Leadership Team 46
May 22, 2017: Spero Therapeutics Appoints Joel Sendek as Chief Financial Officer 47
Government and Public Interest 48
Jan 29, 2018: Motif Bio, Spero Therapeutics and Vical Join Antimicrobials Working Group 48
Product News 49
05/30/2017: Spero Therapeutics Presents New Data on Lead Potentiator Candidate SPR741 at ASM Microbe 2017 49
05/30/2017: Spero Therapeutics Presents New Data on SPR720 at ASM Microbe 2017 51
05/04/2017: Spero Therapeutics Receives Grant from National Institutes of Health to Explore Novel Treatment Combinations for Tuberculosis 52
03/30/2017: Spero Therapeutics Receives $6.8 Million Award from CARB-X to Combat Antibiotic-Resistant Bacteria 53
Clinical Trials 54
Jun 05, 2018: Spero Therapeutics to Present Data On SPR720 at ASM Microbe 2018 54
Oct 03, 2017: Spero Therapeutics Announces Positive Phase 1 Clinical Data From Potentiator Platform 55
Apr 18, 2017: Spero Therapeutics Highlights Potentiator Program Data at the 27th European Congress of Clinical Microbiology and Infectious Diseases 56
Appendix 57
Methodology 57
About GlobalData 57
Contact Us 57
Disclaimer 57
Spero Therapeutics Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Spero Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Spero Therapeutics Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Spero Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Spero Therapeutics Inc, Deals By Therapy Area, 2012 to YTD 2018 9
Spero Therapeutics Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Spero Therapeutics Acquires Next Generation Antibacterial Candidates from Pro Bono Bio 12
Spero Therapeutics Acquires Rights to Novel Gyrase Inhibitors from Vertex Pharma 13
Spero Therapeutics Acquires Antibiotic Assets from Biota Pharma (Aviragen Therapeutics) 14
Spero Therapeutics Raises USD51.7 Million in Series C Financing 15
Spero Therapeutics Raises USD30 Million in Series B Funding 17
Spero Therapeutics Raises USD30 Million in Extended Series A Financing 19
Spero Therapeutics Secures Venture Funding 21
Spero Therapeutics Raises USD3 Million in Series A Venture Financing 22
Spero Therapeutics Enters into Agreement with US Department of Defense 23
Evotec Extends its Agreement with Spero Therapeutics 24
Spero Therapeutics Enters into Licensing Agreement with Meiji Seika Pharma 25
Spero Therapeutics Enters into Licensing Agreement with Promiliad Biopharma 26
Spero Therapeutics Amends Licensing Agreement with Northern Antibiotics 27
Spero Therapeutics Raises USD75 Million in Public Offering of Shares 28
Spero Therapeutics Raises USD77 Million in IPO 30
Spero Therapeutics Inc, Key Competitors 32
Spero Therapeutics Inc, Key Employees 33
Spero Therapeutics Inc, Other Locations 34
Spero Therapeutics Inc, Subsidiaries 34
List of Figures
Spero Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Spero Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Spero Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Spero Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Spero Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Spero Therapeutics Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Spero Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Spero Therapeutics Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9